Metyrapone treatment in endogenous Cushing’s syndrome: Results at week 12 from PROMPT, a prospective international multicenter, open-label, phase III/IV study - Nieman, L K; Scaroni, C M; Deutschbein, T (J Endocr Soc, 2021)